Fradet Y - Search Results

1

PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.

Inman BA, Sebo TJ, Frigola X, Dong H, Bergstralh EJ, Frank I, Fradet Y, Lacombe L, Kwon ED. Inman BA, et al. Among authors: fradet y. Cancer. 2007 Apr 15;109(8):1499-505. doi: 10.1002/cncr.22588. Cancer. 2007. PMID: 17340590 Free article.

2

DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells.

Wheeless LL, Reeder JE, O'Connell MJ, Robinson RD, Cosgriff JM, Fradet Y, Frank IN, Cockett AT. Wheeless LL, et al. Among authors: fradet y. Cytometry. 1991;12(2):140-6. doi: 10.1002/cyto.990120207. Cytometry. 1991. PMID: 2049971 Free article.

3

Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder.

Huffman JL, Fradet Y, Cordon-Cardo C, Herr HW, Pinsky CM, Oettgen HF, Old LJ, Whitmore WF Jr, Melamed MR. Huffman JL, et al. Among authors: fradet y. Cancer Res. 1985 Oct;45(10):5201-4. Cancer Res. 1985. PMID: 4027997

4

Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells.

Bonner RB, Hemstreet GP 3rd, Fradet Y, Rao JY, Min KW, Hurst RE. Bonner RB, et al. Among authors: fradet y. Cancer. 1993 Oct 15;72(8):2461-9. doi: 10.1002/1097-0142(19931015)72:8<2461::aid-cncr2820720826>3.0.co;2-c. Cancer. 1993. PMID: 8402463

5

Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies.

Bostwick DG, Wheeler TM, Blute M, Barrett DM, MacLennan GT, Sebo TJ, Scardino PT, Humphrey PA, Hudson MA, Fradet Y, Miller GJ, Crawford ED, Blumenstein BA, Mahran HE, Miles BJ. Bostwick DG, et al. Among authors: fradet y. Urology. 1996 Jul;48(1):47-57. doi: 10.1016/s0090-4295(96)00149-5. Urology. 1996. PMID: 8693651

6

[Clinical value of the study of proliferation and cell activation antigens with flow cytometry in bladder cancer].

Lacombe L, Gauthier J, Lafleur L, Fradet Y. Lacombe L, et al. Among authors: fradet y. Prog Urol. 1996 Dec;6(6):907-12. Prog Urol. 1996. PMID: 9235176 French.

7

Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors.

Pfister C, Lacombe L, Vezina MC, Moore L, Larue H, Têtu B, Meyer F, Fradet Y. Pfister C, et al. Among authors: fradet y. Hum Pathol. 1999 Nov;30(11):1350-5. doi: 10.1016/s0046-8177(99)90067-9. Hum Pathol. 1999. PMID: 10571516

8

Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.

Pfister C, Moore L, Allard P, Larue H, Lacombe L, Têtu B, Meyer F, Fradet Y. Pfister C, et al. Among authors: fradet y. Clin Cancer Res. 1999 Dec;5(12):4079-84. Clin Cancer Res. 1999. PMID: 10632343

9

Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.

Pfister C, Larue H, Moore L, Lacombe L, Veilleux C, Tetu B, Meyer F, Fradet Y. Pfister C, et al. Among authors: fradet y. Int J Cancer. 2000 Jan 20;89(1):100-4. Int J Cancer. 2000. PMID: 10719738

10

Can biological markers predict recurrence and progression of superficial bladder cancer?

Fradet Y, Lacombe L. Fradet Y, et al. Curr Opin Urol. 2000 Sep;10(5):441-5. doi: 10.1097/00042307-200009000-00013. Curr Opin Urol. 2000. PMID: 11005449 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters